Drainage before surgery for pancreatic cancer with jaundice
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests a specific drainage step before surgery for patients with pancreatic head cancer who have severe jaundice. It aims to see if this approach improves outcomes compared to standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with pancreatic head cancer, confirmed by biopsy or a team of specialists.
- Your jaundice is caused by the tumor blocking the bile duct, and you are scheduled for a Whipple surgery.
- Your bilirubin level is 250 µmol/L or higher, and you have not had any bile duct drainage yet.
- You are between 18 and 75 years old.
- You are well enough to undergo surgery, with an ECOG performance status of 2 or lower.
- You can provide written consent, receive a preoperative endoscopic drainage procedure (ERCP), and be evaluated for the timing of radical surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of four drugs (liposomal irinotecan, 5-fluorouracil, oxaliplatin, and adebrelimab) given with radiation therapy before surgery for pancreatic cancer that can be surgically removed or is borderline removable. The goal is to shrink the tumor and improve the chances of successful surgery.
This trial compares two ways of relieving jaundice before surgery for patients with a blocked bile duct due to cancer. The goal is to see which method leads to better outcomes and fewer complications during surgery.
This study compares different ways doctors drain bile when a tumor blocks the duct and causes jaundice. It looks at real-world results to find which technique works best for patients like you.
This study compares keeping a temporary drainage tube in place after pancreatic surgery versus removing it right after surgery. It aims to see which approach leads to better recovery and fewer complications for people with jaundice caused by a blocked bile duct.
This trial tests a combination of chemotherapy drugs given before and after surgery for pancreatic cancer that is considered high-risk but removable. The goal is to see if this approach can improve outcomes for patients with this type of cancer.
This trial tests a combination of an immunotherapy drug (adebrelimab) with chemotherapy before surgery for pancreatic cancer. The goal is to see if this approach can shrink the tumor and improve outcomes for patients whose cancer can be surgically removed.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.